-+ 0.00%
-+ 0.00%
-+ 0.00%

NurExone signs binding MOU with Made Scientific for exclusive US GMP exosome manufacturing partnership

PUBT·08/13/2026 08:09:56
Listen to the news
NurExone signs binding MOU with Made Scientific for exclusive US GMP exosome manufacturing partnership
  • NurExone signed a binding MOU with Made Scientific for an exclusive U.S. GMP manufacturing and commercial exosome supply partnership.
  • Deal covers manufacturing and aseptic fill-finish of bone marrow-derived exosomes to support clinical development and future commercial supply.
  • Technology transfer starts immediately; first GMP exosome batches targeted for H1 2027.
  • Made Scientific operates a 60,000-square-foot FDA and EU GMP Annex 1 compliant facility in Princeton, New Jersey.
  • Definitive agreement targeted within six months; proposed five-year term with five-year renewal options, or MOU exclusivity terminates.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NurExone Biologic Inc. published the original content used to generate this news brief on August 13, 2026, and is solely responsible for the information contained therein.